Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study

BACKGROUND: In patients with idiopathic pulmonary fibrosis (IPF), continuing treatment with antifibrotic agents is crucial to decrease the reduction of forced vital capacity and mortality rate. However, predictive factors for the discontinuation of antifibrotic agents are unknown. This study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Oishi, Keiji, Hirano, Tsunahiko, Murata, Yoriyuki, Hamada, Kazuki, Uehara, Sho, Suetake, Ryo, Yamaji, Yoshikazu, Asami-Noyama, Maki, Edakuni, Nobutaka, Ohata, Syuichiro, Utsunomiya, Toshiaki, Sakamoto, Kenji, Onoda, Hideko, Matsumoto, Tsuneo, Matsunaga, Kazuto, Yano, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719482/
https://www.ncbi.nlm.nih.gov/pubmed/31476961
http://dx.doi.org/10.1177/1753466619872890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719482/
https://www.ncbi.nlm.nih.gov/pubmed/31476961
http://dx.doi.org/10.1177/1753466619872890

Ejemplares similares